Predicate |
Object |
contentType |
Journal Article |
endingPage |
2656 |
issn |
1179-1950 0012-6667 |
issueIdentifier |
17 |
pageRange |
2655-2656 |
publicationName |
Drugs |
startingPage |
2655 |
bibliographicCitation |
Brandwein J. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein. Drugs. 2007;67(17):2655. doi: 10.2165/00003495-200767170-00014. PMID: 18034600. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce514e20129e1d3e19d2a271b3967fb5 |
date |
200712 |
identifier |
https://doi.org/10.2165/00003495-200767170-00014 https://pubmed.ncbi.nlm.nih.gov/18034600 |
isPartOf |
https://portal.issn.org/resource/ISSN/0012-6667 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453 https://portal.issn.org/resource/ISSN/1179-1950 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein |
discusses |
http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0016884 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870 |